Evidence map›Paper›PMID 8344574›Full record

ArticleGut1993

Acid secretion and sensitivity to gastrin in patients with duodenal ulcer: effect of eradication of Helicobacter pylori.

S F Moss, J Calam

Open access · bronzeAbstract read
In one paragraph

Article in Gut, 1993. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed
19.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 183 citations in OpenAlex.

  1. Gastrin and the Moderate Hypergastrinemias.International journal of molecular sciences · 2021
    Review
  2. Article
  3. Clinical and experimental gastroenterology · 2019
    Article
  4. Helicobacter pylori seropositivities and risk of pancreatic carcinoma.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2014
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Antiulcer drugs and gastric cancer.Digestive diseases and sciences · 2005
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

S F MossGastroenterology Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London.
J Calam
Hammersmith Hospital · GB

Funding

Wellcome Trust
6 · The paper itself

Abstract

The effect of ulcer healing with eradication of Helicobacter pylori (H pylori) on gastric function was investigated in nine patients with duodenal ulcer disease. One month after eradication there were significant reductions in both basal plasma gastrin concentration, from a median (range) of 19 (1-22) to 6 (2-15) pmol/l (p < 0.05), and of basal acid secretion from 8.3 (2.4-24) to 2.6 (1.4-8.1) mM H+/h, (p < 0.01). The peak acid secretion rate was unchanged from 37 (16-59) to 37 (21-59) mM H+/h. After treatment there was no change in the parietal cell sensitivity to stepped infusions of gastrin heptadecapeptide: the median concentration of gastrin required for 50% of maximal acid secretion (EC50) was 41 (14.8-126) before and 33 (23-125) pmol/l after eradication of H pylori. The metabolic clearance rate of gastrin was also unaffected by the eradication of H pylori. Thus eradication of H pylori infection from patients with active duodenal ulcers is accompanied by falls in both basal gastrin release and basal acid secretion without a change in the parietal cell sensitivity to gastrin. Cyclical changes in H pylori infection may cause the variations in basal acid secretion that are seen in duodenal ulcer disease.

Indexed as

Helicobacter pyloriAcute DiseaseAdultAgedBismuthDrug Therapy, CombinationDuodenal UlcerGastric AcidGastrinsHelicobacter InfectionsHumansMaleMetronidazoleMiddle AgedOrganometallic CompoundsParietal Cells, GastricBismuthbismuth tripotassium dicitrategastrin 17GastrinsMetronidazoleOrganometallic CompoundsTetracycline

Identifiers

PMID8344574
PMCPMC1374220
OpenAlexW2133329092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.